Biomarkers in uncomplicated patients with CVD/Hypertension. حسب Sebastian Cremer (11592273)

الموضوعات:

Biomarkers in all patients with CVD/Hypertension. حسب Sebastian Cremer (11592273)

الموضوعات:

Baseline characteristics of patients included in the study. حسب Sebastian Cremer (11592273)

الموضوعات:

Association between severity and potential risk factors among 123 COVID-19 patients in multiple multinomial logistic regression analysis. حسب Yingji Chen (5258498)

الموضوعات:

Initial participants by wave*. حسب Yeo Ju Sohn (18536198)

الموضوعات:

General characteristics of research participants. حسب Yeo Ju Sohn (18536198)

الموضوعات:

Flow chart. حسب Raphaele Houlbracq (20558509)

الموضوعات:

ASIR prediction from 2020 to 2030 by sex. حسب Majed M. Ramadan (22379116)

"…Bahrain also saw a significant increase in male Age-standardized death rate (ASDR), despite all other countries experiencing a decrease. …"

The ASDR of hypertension-related AA in each age group globally predicted by the BAPC model from 2022 to 2050. حسب Guanghui Yu (423945)

الموضوعات:

DataSheet_1_Decreased CD73+ Double-Negative T Cells and Elevated Level of Soluble CD73 Correlated With and Predicted Poor Immune Reconstitution in HIV-Infected Patients After Antir... حسب Xinyue Wang (286629)

"…These PIRs were at a high risk of AIDS-related and non-AIDS complications, resulting in higher morbidity and mortality rate. …"

Anaesthesia decreases stimulus-specific suppression on probe-responses only after communication context. حسب Luciana López-Jury (8601540)

The ASDR of hypertension – related AA in different age groups of man worldwide from 2022 to 2050 predicted by the BAPC model. حسب Guanghui Yu (423945)

الموضوعات:

The ASDR of hypertension – related AA in different age groups of women worldwide from 2022 to 2050 predicted by the BAPC model. حسب Guanghui Yu (423945)

الموضوعات:

Low-density lipoprotein cholesterol (LDL-C) level-dependent receiver operating characteristic (ROC) curve analysis of <i>MUC4</i> rs1104760 A>G and colorectal cancer risk. حسب Min Jung Kwon (10129073)

الموضوعات:

OS correlation of differentially expressed miRNAs (> 2-fold increase or decrease in HCC vs normal livers), according to KMP; miRNAs in bold are significantly correlated with OS. حسب Kayleigh Smith (17816667)

Meta-analysis of load (watts) and morbidity. حسب Nabeela Arbee-Kalidas (17598969)

"…Higher estimates of peak, measured and as a percentagege of predicted, showed significant associations with a lower risk of mortality [MD: 3.66, 95% CI: 0.88; 6.43 and MD: 16.49, 95% CI: 6.92; 26.07] and fewer complications [MD: 2.06, 95% CI: 1.12; 3.00 and MD: 9.82, 95% CI: 5.88; 13.76]. …"

Meta-analysis of peak (mL/kg/min) and morbidity. حسب Nabeela Arbee-Kalidas (17598969)

"…Higher estimates of peak, measured and as a percentagege of predicted, showed significant associations with a lower risk of mortality [MD: 3.66, 95% CI: 0.88; 6.43 and MD: 16.49, 95% CI: 6.92; 26.07] and fewer complications [MD: 2.06, 95% CI: 1.12; 3.00 and MD: 9.82, 95% CI: 5.88; 13.76]. …"

Meta-analysis of AT (ml/kg/min) and morbidity. حسب Nabeela Arbee-Kalidas (17598969)

"…Higher estimates of peak, measured and as a percentagege of predicted, showed significant associations with a lower risk of mortality [MD: 3.66, 95% CI: 0.88; 6.43 and MD: 16.49, 95% CI: 6.92; 26.07] and fewer complications [MD: 2.06, 95% CI: 1.12; 3.00 and MD: 9.82, 95% CI: 5.88; 13.76]. …"

Meta-analysis of and morbidity. حسب Nabeela Arbee-Kalidas (17598969)

"…Higher estimates of peak, measured and as a percentagege of predicted, showed significant associations with a lower risk of mortality [MD: 3.66, 95% CI: 0.88; 6.43 and MD: 16.49, 95% CI: 6.92; 26.07] and fewer complications [MD: 2.06, 95% CI: 1.12; 3.00 and MD: 9.82, 95% CI: 5.88; 13.76]. …"

Meta-analysis of peak (L/min) and morbidity. حسب Nabeela Arbee-Kalidas (17598969)

"…Higher estimates of peak, measured and as a percentagege of predicted, showed significant associations with a lower risk of mortality [MD: 3.66, 95% CI: 0.88; 6.43 and MD: 16.49, 95% CI: 6.92; 26.07] and fewer complications [MD: 2.06, 95% CI: 1.12; 3.00 and MD: 9.82, 95% CI: 5.88; 13.76]. …"